← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bastyr University
Kenmore, WA
$17,539,630
Total funding
23
Grants
Funding over time
peak $4M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$17,539,630 · 23
By mechanism
U19$4,585,603 · 4
R01$3,613,969 · 3
T32$3,199,887 · 1
R21$2,176,502 · 7
K01$1,676,178 · 3
R25$826,793 · 1
Investigators at Bastyr University
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Bastyr/UW Oncomycology Translational Research Center$1,207,565
U19 · FY2012 · AT
Bastyr/UW Oncomycology Translational Research Center$1,147,443
U19 · FY2010 · AT
Bastyr/UW Oncomycology Translational Research Center$1,106,200
U19 · FY2011 · AT
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish$897,391
U19 · FY2011 · AT
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish$827,215
U19 · FY2012 · AT
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish$686,787
U19 · FY2013 · AT
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$612,433
R01 · FY2012 · AT
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$597,510
R01 · FY2013 · AT
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$593,668
R01 · FY2010 · AT
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish$590,985
U19 · FY2010 · AT
Training in Complementary and Alternative Medical Research$581,092
T32 · FY2009 · AT
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$568,938
R01 · FY2011 · AT
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner$556,458
U19 · FY2010 · AT
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner$504,417
U19 · FY2011 · AT
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$481,558
R01 · FY2014 · AT
Training in Complementary &Alternative Medical Research$470,376
T32 · FY2004 · AT
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner$380,350
U19 · FY2012 · AT
METHODS IN COMPLEMENTARY/ALTERNATIVE MEDICINE &HIV/AIDS$375,652
R01 · FY2000 · AT
Training in Complementary and Alternative Medical Research$352,546
T32 · FY2010 · AT
Training in Complementary and Alternative Medical Research$313,176
T32 · FY2007 · AT